Kilow is a Riyadh-based digital-health company building what it calls Saudi Arabia's first comprehensive, Arabic-first weight-loss platform. It blends modern medicine, real physician supervision, and behavior change into a single app, using AI to make the experience personal and adaptive. Rather than offering a generic diet, Kilow's AI tailors nutrition, sleep, and exercise recommendations to each user and adjusts those plans over time as progress, lab results, and adherence data come in.
The platform is built around medical legitimacy and convenience. Users complete a short health intake and receive a free medical consultation; after approval, they choose from flexible plans and gain access to licensed medical consultations, at-home lab testing, real-time health tracking, home delivery of medications and health essentials, and, where clinically appropriate, optional GLP-1 medications. The combination is designed to mirror a supervised clinical program while remaining accessible from a phone.
What distinguishes Kilow is its cultural relevance. Instead of asking users to abandon traditional eating patterns, the platform specializes in teaching people how to adapt their existing diets, an approach intended to make change sustainable in the Saudi context rather than imposing foreign models that rarely stick. This localization extends across the product, from language to coaching to the integrated marketplace of health essentials.
Kilow was founded in 2024 by digital-health entrepreneur and four-time founder Fahed Al-Essa. In May 2025 it raised a 2.5 million US dollar seed round led by Sanabil Venture Studio, a joint venture between Sanabil Investments and Stryber. The company plans to use the capital to expand operations, enhance its AI models, and deepen localization for the Saudi market as it scales its integrated, medically supervised approach to sustainable weight management.